Within our genomics core facility, we have established an extensive portfolio of RNA-targeted genomics methods to comprehensively characterize mRNA and miRNA expression and dynamics, translation, RNA-protein interactions, and RNA structure in pathophysiological contexts.
- Illumina NextSeq™ 2000 sequencing system
- 4150 TapeStation system
- Bioanalyzer 2100 instrument
- QuantStudio™ 3 & 5 Real-Time-PCR systems
- Biocomp Gradient Station™
We gladly share our expertise and provide access to our genomics facility.